Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Journal of Clinical Lipidology|December 20, 2014
National Lipid Association Annual Summary of Clinical Lipidology 2015Harold E Bays, Peter H Jones, W Virgil Brown, et al.
The American Journal of Medicine|July 26, 2017
Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor TherapeuticsJames A Underberg, Michael J Blaha, Elizabeth J Jackson, et al.
Current Opinion in Lipidology|May 29, 2004
Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'Ashok Balasubramanyam, Rajagopal V Sekhar, Farook Jahoor, et al.
Journal of Clinical Lipidology|October 16, 2018
Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponseAnum Saeed, Salim S Virani, Peter H Jones, et al.
Journal of Clinical Lipidology|February 20, 2016
National Lipid Association Annual Summary of Clinical Lipidology 2016Harold E Bays, Peter H Jones, Carl E Orringer, et al.
Current Atherosclerosis Reports|June 20, 2018
Correction to: Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future DirectionsAnum Saeed, Kaustubh Dabhadkar, Salim S Virani, et al.
Current Atherosclerosis Reports|May 22, 2018
Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future DirectionsAnum Saeed, Kaustubh Dabhadkar, Salim S Virani, et al.
Pageof 10